Confidence: 85%
B0F7FBS763
View on Amazon →Decision summary
A middling option. It may be usable, but weaker ingredient form quality makes better alternatives worth comparing.
Best for
Buyers comparing price and availability and okay with a middle-of-the-pack option.
Consider another option if
You prefer fully transparent formulas over blends and ambiguous labeling.
Score breakdown
Tap a module to see what it measures. A 0 can reflect missing disclosure, not just a negative result.
Dosage quality
4.7/10Dosing looks weaker than ideal
Checks whether labeled ingredient amounts fall within clinically studied ranges (not just regulatory minimums). Low/0 can reflect under-dosing or missing amounts (e.g., proprietary blends).
Chromium: dose within clinically studied range (evidence B). The main limitation is that proprietary blend prevents independent dose verification.
Strengths
Weaknesses
Final verdict
A middling option. It may be usable, but weaker ingredient form quality makes better alternatives worth comparing.
A closer look at the main ingredients, how they influence the score, and the supporting evidence when available. Tap any ingredient to expand.
ℹ Evidence is strong, but dose is below the optimal range
One of the weaker points: Dose is below the ranges usually used for stronger effects. The declared form is acceptable, but not among the best-absorbed options.
Scientific evidence
Lan et al. meta-analysis berberine and lipid profile
Journal of Ethnopharmacology • 2015
PMID: 26448206.0
Dong et al. meta-analysis berberine and glycemic control in type 2 diabetes
Metabolism • 2012
PMID: 22162995.0
⚠ Limited evidence exists, and dose is below effective threshold
One of the weaker points: Dose is likely below clinically useful levels.
Scientific evidence
Shanmugasundaram et al. RCT Gymnema sylvestre and type 2 diabetes
Journal of Ethnopharmacology • 1990
PMID: 1308070.0
✔ Clinically effective dose with moderate supporting evidence
A clear strength: Dose is strong and within effective ranges. The declared form supports strong absorption.
Scientific evidence
Balk et al. systematic review chromium picolinate and glycemic control
Diabetes Technology & Therapeutics • 2007
PMID: 17519436.0
ℹ Dose is within established clinical ranges, but lacks direct studies
Strong contributor: Dose is strong and within effective ranges.
Clinical dosing guidance
Based on established dosing ranges used in clinical practice.
Evidence inferred from established knowledge, not directly linked studies
Adequate, but not a key strength: Clinical dosing guidance is limited for this ingredient.
No supporting studies or dosing references are currently available for this ingredient.
Important label or formulation details that may affect how this product should be interpreted.
Proprietary blend limits dose transparency
Exact ingredient amounts cannot be verified clearly.
Gymnema dose looks below clinically effective levels
Declared amount falls below ranges used in human trials.
Read our methodology overview to understand how SuppScoreLab combines multiple scientific dimensions into one practical score.
View methodology →This evaluation is based on the product label and declared Supplement Facts available at review time. It does not verify laboratory-tested composition, purity, or batch-level quality. This content is educational and not medical advice. Consult a qualified healthcare professional for personal health decisions. Affiliate disclosure: SuppScoreLab may earn a commission from qualifying Amazon links.
See the best CoQ10 supplements ranked with the same methodology, or keep exploring the database.
